Literature DB >> 19966212

Immunostimulatory RNA blocks suppression by regulatory T cells.

David Anz1, Viktor H Koelzer, Stefan Moder, Raffael Thaler, Tobias Schwerd, Katharina Lahl, Tim Sparwasser, Robert Besch, Hendrik Poeck, Veit Hornung, Gunther Hartmann, Simon Rothenfusser, Carole Bourquin, Stefan Endres.   

Abstract

The role of immune suppression by regulatory T (Treg) cells in the maintenance of immune homeostasis is well established. However, little is known about how Treg cell function is inhibited on viral infection to allow the development of a protective immune response. As viral RNA is a crucial mediator for activation of antiviral immunity, we examined the effects of immunostimulatory RNA and infection with RNA viruses on Treg cell function. We show that synthetic RNA oligonucleotides potently inhibit Treg cell-induced suppression in a sequence-dependent manner. This effect is entirely dependent on TLR7 activation of APCs and subsequent IL-6 production. In addition, stimulation with the RNA viruses encephalomyocarditis virus and Sendai virus that specifically activate the RNA-sensing helicases melanoma differentiation-associated gene 5 (MDA-5) and retinoic acid-inducible gene I (RIG-I) also blocks Treg cell function. Interestingly, this effect is seen even in the absence of APCs. Consistent with this, both Treg and T effector cells express RIG-I and MDA-5. Using MDA-5-deficient mice, we demonstrate that the loss of Treg cell function on infection with encephalomyocarditis virus is strictly dependent on MDA-5 expression by Treg cells. Thus, we show in this study for the first time that activation of a RIG-I-like helicase on Treg cells blocks their suppressive function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966212     DOI: 10.4049/jimmunol.0901245

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers.

Authors:  Cecilia Hermans; David Anz; Jutta Engel; Thomas Kirchner; Stefan Endres; Doris Mayr
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

2.  Epitope-specific regulatory CD4 T cells reduce virus-induced illness while preserving CD8 T-cell effector function at the site of infection.

Authors:  Jie Liu; Tracy J Ruckwardt; Man Chen; John D Nicewonger; Teresa R Johnson; Barney S Graham
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

3.  Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection.

Authors:  Ankit Bharat; Elbert Kuo; Deepti Saini; Nancy Steward; Ramsey Hachem; Elbert P Trulock; G Alexander Patterson; Bryan F Meyers; Thalachallour Mohanakumar
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

Review 4.  Immune signaling by RIG-I-like receptors.

Authors:  Yueh-Ming Loo; Michael Gale
Journal:  Immunity       Date:  2011-05-27       Impact factor: 31.745

Review 5.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 6.  Regulatory T-cell homeostasis: steady-state maintenance and modulation during inflammation.

Authors:  Kate S Smigiel; Shivani Srivastava; J Michael Stolley; Daniel J Campbell
Journal:  Immunol Rev       Date:  2014-05       Impact factor: 12.988

7.  Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiation.

Authors:  Marc Beyer; Yasser Thabet; Roman-Ulrich Müller; Timothy Sadlon; Sabine Classen; Katharina Lahl; Samik Basu; Xuyu Zhou; Samantha L Bailey-Bucktrout; Wolfgang Krebs; Eva A Schönfeld; Jan Böttcher; Tatiana Golovina; Christian T Mayer; Andrea Hofmann; Daniel Sommer; Svenja Debey-Pascher; Elmar Endl; Andreas Limmer; Keli L Hippen; Bruce R Blazar; Robert Balderas; Thomas Quast; Andreas Waha; Günter Mayer; Michael Famulok; Percy A Knolle; Claudia Wickenhauser; Waldemar Kolanus; Bernhard Schermer; Jeffrey A Bluestone; Simon C Barry; Tim Sparwasser; James L Riley; Joachim L Schultze
Journal:  Nat Immunol       Date:  2011-08-14       Impact factor: 25.606

8.  Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses.

Authors:  Christian Hotz; Marina Treinies; Ines Mottas; Laurin C Rötzer; Anne Oberson; Lorenzo Spagnuolo; Maurizio Perdicchio; Thibaud Spinetti; Tina Herbst; Carole Bourquin
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

9.  TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function.

Authors:  Thibaud Spinetti; Lorenzo Spagnuolo; Inès Mottas; Chiara Secondini; Marina Treinies; Curzio Rüegg; Christian Hotz; Carole Bourquin
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

10.  Lung Injury Combined with Loss of Regulatory T Cells Leads to De Novo Lung-Restricted Autoimmunity.

Authors:  Stephen Chiu; Ramiro Fernandez; Vijay Subramanian; Haiying Sun; Malcolm M DeCamp; Daniel Kreisel; Harris Perlman; G R Scott Budinger; Thalachallour Mohanakumar; Ankit Bharat
Journal:  J Immunol       Date:  2016-05-18       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.